MENU
+Compare
DVAX
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$12.77
Change
-$0.13 (-1.01%)
Capitalization
1.62B

DVAX Dynavax Technologies Corp Forecast, Technical & Fundamental Analysis

a developer of novel products to prevent and treat infectious diseases

DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for DVAX with price predictions
Dec 17, 2024

DVAX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for DVAX moved above the 200-day moving average on November 27, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on DVAX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DVAX advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 199 cases where DVAX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DVAX moved out of overbought territory on November 15, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where DVAX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DVAX turned negative on November 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DVAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.641) is normal, around the industry mean (57.958). P/E Ratio (31.634) is within average values for comparable stocks, (89.727). DVAX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (6.974) is also within normal values, averaging (19.472).

View a ticker or compare two or three
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DVAX is expected to report earnings to fall 66.00% to 4 cents per share on February 20

Dynavax Technologies Corp DVAX Stock Earnings Reports
Q4'24
Est.
$0.04
Q3'24
Est.
$0.12
Q2'24
Beat
by $0.02
Q1'24
Missed
by $0.05
Q4'23
Beat
by $0.03
The last earnings report on November 07 showed earnings per share of 11 cents, meeting the estimate of 11 cents. With 1.79M shares outstanding, the current market capitalization sits at 1.62B.
A.I. Advisor
published General Information

General Information

a developer of novel products to prevent and treat infectious diseases

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2100 Powell Street
Phone
+1 510 848-5100
Employees
408
Web
https://www.dynavax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPCGX30.91-0.26
-0.83%
Fort Pitt Capital Total Return
NMPAX15.03-0.17
-1.12%
Columbia Mid Cap Index Inst
JVMSX30.72-0.36
-1.16%
JHancock Disciplined Value Mid Cap R2
HWVZX12.79-0.17
-1.31%
Hotchkis & Wiley Sm Cp Divers Val Z
KSDVX19.16-0.26
-1.34%
Keeley Small Cap Dividend Value A

DVAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.39%
ACET - DVAX
39%
Loosely correlated
-0.75%
SNDL - DVAX
35%
Loosely correlated
+4.17%
SUPN - DVAX
34%
Loosely correlated
-0.74%
AMPH - DVAX
32%
Poorly correlated
+0.02%
IRWD - DVAX
27%
Poorly correlated
+2.32%
More